COMPUGEN
LIVE

Serial Number

87284523

Owner

COMPUGEN LTD.

Attorney

Kevin D. McCarthy

First Use Date

Sep 8, 2004

Filing Date

Dec 29, 2016

Add to watchlist:

No watchlists yet
View on USPTO

COMPUGEN Trademark

Serial Number: 87284523 • Registration: 5640243

COMPUGEN is a trademark filed by COMPUGEN LTD. on December 29, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 45 (Legal & Security Services). The application is currently registered and active.

Owner Contact Info

COMPUGEN LTD. (28 trademarks)

72 Pinchas Rosen St.
Tel Aviv 69512 , IL

Entity Type: 11

Trademark Details

Filing Date

December 29, 2016

Registration Date

January 1, 2019

First Use Anywhere

September 8, 2004

First Use in Commerce

September 8, 2004

Published for Opposition

October 16, 2018

Goods & Services

[ (Based on 44(e)) biological preparations featuring antibodies for the treatment of cancer, inflammatory diseases, autoimmune diseases, neurological diseases, cardiovascular diseases, metabolic diseases, gastrointestinal diseases; anti-cancer preparations; biological preparations for the treatment of cancer inflammatory diseases, autoimmune diseases, neurological diseases, cardiovascular diseases, metabolic diseases, gastrointestinal diseases; biopharmaceuticals for the treatment of cancer; diagnostic reagents for medical purposes; pharmaceutical preparations for the treatment of autoimmune diseases ]

[ (Based on 44(e)) Licensing of intellectual property rights ]

(Based on Use in Commerce) (Based on 44(e)) Drug discovery services; scientific research for medical purposes in the area of cancerous diseases; scientific research in the field of genetics; research and development in the field of diagnostic preparations; research in the field of pharmacogenetics; conducting clinical trials for pharmaceuticals; pharmaceutical research and development; research and development in the field of pharmaceuticals for the pharmaceutical industry; conducting early evaluations in the field of new pharmaceuticals; research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; structural and functional analysis of genomes; DNA screening for scientific research purposes; biochemical research and analysis; laboratory research in the field of pharmaceuticals; research and development services in the field of immunology; medical research in the nature of computerized genetic analysis of DNA

Filing History

NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sep 10, 2024 NA85
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sep 10, 2024 C15P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sep 10, 2024 APRE
TEAS SECTION 8 & 15 RECEIVED
Feb 27, 2024 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jan 1, 2024 REM1
REGISTERED-PRINCIPAL REGISTER
Jan 1, 2019 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 16, 2018 NPUB
PUBLISHED FOR OPPOSITION
Oct 16, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 26, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 6, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 17, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 17, 2018 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 15, 2018 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
May 6, 2018 GNS2
INQUIRY TO SUSPENSION E-MAILED
May 6, 2018 GNSI
SUSPENSION INQUIRY WRITTEN
May 6, 2018 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 26, 2018 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Oct 14, 2017 GNS3
LETTER OF SUSPENSION E-MAILED
Oct 14, 2017 GNSL
SUSPENSION LETTER WRITTEN
Oct 14, 2017 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 19, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 2017 CRFA
ASSIGNED TO LIE
Sep 15, 2017 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 7, 2017 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 2, 2017 GNRN
NON-FINAL ACTION E-MAILED
Apr 2, 2017 GNRT
NON-FINAL ACTION WRITTEN
Apr 2, 2017 CNRT
ASSIGNED TO EXAMINER
Mar 26, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 10, 2017 NWOS
NEW APPLICATION ENTERED
Jan 2, 2017 NWAP